Avrobio (AVRO) is said to be working with bankers to explore a potential sale after being approached by Novartis (NVS) about a takeover, a source told Street Insider. The price offered is "said to be more than quadruple the current market price," the source claimed, according to the blog report. Avrobio shares are up 20c, or 23%, to $1.07 following the report.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AVRO: